FibroGen to Report Fourth Quarter and Full Year 2022 Financial Results
17 févr. 2023 07h00 HE
|
FibroGen, Inc.
SAN FRANCISCO, Feb. 17, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its fourth quarter and full year 2022 financial results on Monday, February 27 after the market close....
Identify, Attract, and Hire Top Talent Faster with AspireHR Recruiting
13 sept. 2022 13h30 HE
|
AspireHR
Las Vegas, NV, Sept. 13, 2022 (GLOBE NEWSWIRE) -- AspireHR, an SAP Gold Partner and one of the largest North American HCM implementation, software, and managed services firms, announced its launch...
Indeed and GR8 People partner to drive passive sourcing with access to over 200 million resumes
20 juin 2022 07h00 HE
|
GR8 People
PHILADELPHIA, June 20, 2022 (GLOBE NEWSWIRE) -- GR8 People, the leading talent acquisition platform to source, attract, engage and hire every workforce type in one seamless experience, announced a...
JobDiva Announces New Integration with CloudCall
08 juin 2022 15h37 HE
|
JobDiva
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- JobDiva is proud to announce a new integration with CloudCall, a computer telephony integration (CTI) designed for CRM. This system will enable recruiters...
aTyr Pharma Presents Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference
17 mai 2022 08h00 HE
|
aTyr Pharma, Inc.
Results from Phase 1b/2a study of efzofitimod in pulmonary sarcoidosis patients demonstrate dose-dependent improvements in key physiologic and quality of life measures in context of a steroid taper. ...
ClearStar Names Three New C-Suite Executives as Company Eyes Unprecedented Growth
26 avr. 2022 17h20 HE
|
ClearStar
ALPHARETTA, Ga., April 26, 2022 (GLOBE NEWSWIRE) -- ClearStar, Inc. ("ClearStar"), a leading HR-technology company specializing in background and medical screening services announces three new...
aTyr Pharma to Present Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference
01 avr. 2022 08h00 HE
|
aTyr Pharma, Inc.
Results from Phase 1b/2a study of efzofitimod in pulmonary sarcoidosis patients demonstrate safety and dose dependent trends of improvement compared to placebo for key efficacy endpoints. Efzofitimod...
Fountain Launches Innovative Suite of Solutions for Sourcing Applicants to Drive Growth of Industry-leading High Volume Hiring Platform
16 mars 2022 09h00 HE
|
Fountain
SAN FRANCISCO, March 16, 2022 (GLOBE NEWSWIRE) -- Fountain, the world's leading applicant tracking system (ATS) for high volume hiring, today announced Fountain Source – a full suite of sourcing...
Socrates.ai and Jobma Announce Alliance to Optimize the Candidate to Employee Journey
10 mars 2022 12h00 HE
|
Socrates.ai
WOODSIDE, Calif. and MOUNTAIN VIEW, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Socrates.ai, a leading employee experience platform, and Jobma, a digital interviewing company that simplifies hiring,...
GR8 People Named a Leader in Talent Acquisition Software Across Four Categories in G2’s Winter 2022 Report and Announces Strong Growth in Fiscal 2021
10 janv. 2022 07h00 HE
|
GR8 People
PHILADELPHIA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- GR8 People, a breakthrough One-Experience Talent Platform for the enterprise, has been named for the third year in a row a High Performer in the...